Your browser doesn't support javascript.
loading
Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand.
van Dantzig, Philippa; Quincey, Vicki; Kurz, Jason; Ming, Caroline; Kamalaksha, Sujatha; White, Douglas.
Afiliação
  • van Dantzig P; Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand.
  • Quincey V; Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand; Waikato Clinical School, The University of Auckland, Hamilton, New Zealand.
  • Kurz J; University of Waikato, Hamilton, New Zealand.
  • Ming C; Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand.
  • Kamalaksha S; Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand; Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
  • White D; Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand; Waikato Clinical School, The University of Auckland, Hamilton, New Zealand.
N Z Med J ; 137(1592): 14-21, 2024 Mar 22.
Article em En | MEDLINE | ID: mdl-38513200
ABSTRACT

AIM:

Giant cell arteritis (GCA) is the most common primary vasculitis in adults over 50 years of age. Our primary objective was to assess the incidence and prevalence of GCA in Waikato in a bid to deepen our understanding of the epidemiology of GCA in Aotearoa New Zealand.

METHODS:

From January 2014 to December 2022, cases of GCA were identified prospectively and retrospectively through temporal artery ultrasound request lists and temporal artery biopsy histology reports. Using electronic health records, data were collected retrospectively on patient demographics and clinical features. These were used to calculate the incidence, prevalence and standardised mortality ratio (SMR) of GCA in Waikato.

RESULTS:

There were 214 patients diagnosed with GCA over the 9-year period. The majority of patients were European (93.9%, 201/214) with Maori patients being significantly younger than European patients. The mean annual incidence of clinical GCA was 14.7 per 100,000 people over 50 years (95% confidence interval [CI] 12.7-16.6). The SMR was 1.18 (95% CI 0.83-1.52).

CONCLUSION:

This is the largest study to date on the epidemiology of GCA in Aotearoa New Zealand. The incidence of GCA is comparable to other studies performed in Aotearoa New Zealand and appears to be stable over time. GCA is uncommon in Maori, Pacific Islander and Asian ethnic groups.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Arterite de Células Gigantes Limite: Humans / Middle aged País/Região como assunto: Oceania Idioma: En Revista: N Z Med J Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Arterite de Células Gigantes Limite: Humans / Middle aged País/Região como assunto: Oceania Idioma: En Revista: N Z Med J Ano de publicação: 2024 Tipo de documento: Article